![In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure–activity relationships and molecular docking]()
In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure–activity relationships and molecular dockingWang, Jiao-Long; Li, Liang; Hu, Mei-Bian; Wu, Bo; Fan, Wen-Xiang; Peng, Wei; Wei, Da-Neng; Wu, Chun-Jie · Computational Biology and Chemistry · 2019